Company profile: Corsair Pharma
1.1 - Company Overview
Company description
- Provider of a transdermal treprostinil prodrug patch for pulmonary arterial hypertension (PAH), designed to deliver consistent blood levels and reduce the need for invasive administration. Develops transformative solutions to improve the therapeutic profile of medications and provide superior treatment for patients.
Products and services
- Transdermal Treprostinil Prodrug Patch: A prodrug-based transdermal patch delivers treprostinil for pulmonary arterial hypertension, sustaining consistent blood levels and cutting reliance on invasive administration methods
- Therapeutic Profile Optimization: A therapeutic-profile-focused system develops transformative medication profiles to achieve consistent blood levels and reduce invasive administration, strengthening treatment benefits for patients
- Patient Treatment Enhancement: A PAH-focused program delivers superior treatment by minimizing invasive administration and preserving consistent blood levels through transdermal treprostinil prodrug therapy
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Corsair Pharma
Lexaria Bioscience
HQ: Canada
Website
- Description: Provider of patented DehydraTECH technology that improves bio-absorption, reduces onset time, and enhances delivery of lipophilic drugs across the blood-brain barrier; out-licenses this platform and operates units focused on pharmaceuticals (hypertension, antiviral, epilepsy), oral non-combusted nicotine, hemp-derived ingredients, a Health Canada licensed lab for cannabinoid and other formulations, and nutraceutical CPG applications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lexaria Bioscience company profile →
Coeur
HQ: United States
Website
- Description: Provider of disposable medical products used in diagnostic imaging and other medical procedures, offering design, manufacturing, and assembly services. A state-of-the-art designer and contract manufacturer for medical and commercial markets, with manufacturing and assembly operations in North Carolina and Wisconsin, and providing regulatory support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Coeur company profile →
Sensile Medical
HQ: Switzerland
Website
- Description: Provider of liquid drug delivery devices and platforms developed in Switzerland, offering safe, cost-efficient, customizable on- and off-body solutions—featuring reusable and disposable concepts—for subcutaneous administration of biologics and small molecules, including Gx SensAir, on-body and belt-worn infusors with adjustable flow and connectivity, an inhalation assessment platform, and the Gx Inbeneo autoinjector.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sensile Medical company profile →
NTT
HQ: United States
Website
- Description: Provider of practical drug delivery systems.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NTT company profile →
RenovoRx
HQ: United States
Website
- Description: Provider of targeted delivery solutions for fluids and chemotherapy to selected sites in the peripheral vascular system and tumors. Products include RenovoGem, a gemcitabine-based combination drug-device for locally advanced pancreatic and bile duct cancers delivered via the TAMP (Trans-Arterial Micro-Perfusion) platform; TAMP for targeted chemotherapy delivery; and RenovoCath for isolating blood flow and delivering diagnostic or therapeutics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full RenovoRx company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Corsair Pharma
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Corsair Pharma
2.2 - Growth funds investing in similar companies to Corsair Pharma
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Corsair Pharma
4.2 - Public trading comparable groups for Corsair Pharma
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →